Letter from the Director

Welcome to the NeuroNetwork for Emerging Therapies. With the brightest minds working together, this is where scientists create cures.

Hello Friends,

Eleanor Roosevelt famously said: “One’s philosophy is not best expressed in words; it is expressed in the choices one makes… and the choices we make are ultimately our responsibility.” I am never shy about my respect for the former First Lady, and her words ring equally as true today as they did when I started my research program, formerly called the Program for Neurology Research and Discovery, over 20 years ago. 

From day one, we have chosen to walk the path of scientific discoveries in the laboratory and translate this research into novel treatments for neurological diseases. I am a scientist, but I am also a physician who cares very much about her patients.

Today, the solo investigator working alone in her lab is a thing of the past. Instead, our work requires bringing together many diverse individuals from a broad spectrum of medical disciplines and great institutions worldwide to collaborate, create, investigate, discover, and, ultimately, treat patients in new ways.  That is the reason we transitioned our Program in 2020 into the NeuroNetwork for Emerging Therapies.

Some say it takes a village. We like to say it takes a Network.

We are unwavering in our efforts to accelerate scientific discovery that will alleviate the suffering caused by neurological diseases.

All of this and much more are featured throughout our new website. Please look and come back often, as we will continue to provide updates on new research and clinical developments.

We are confident that by harnessing the brightest minds in medicine, the NeuroNetwork for Emerging Therapies is where the impossible becomes routine and scientists, as our motto goes, create cures.

Warmly,

Eva Feldman, M.D., Ph.D.
Russell N. DeJong Professor of Neurology
Director, NeuroNetwork for Emerging Therapies
Director, ALS Center of Excellence at Michigan Medicine